LONDON, May 8, 2014 /PRNewswire/ --

The trading session on Wednesday, May 07, 2014 ended on a mixed note as the Dow Jones Industrial Average finished at 16,518.54, up 0.72% and the NASDAQ Composite closed at 4,067.67, down 0.32%. The S&P 500 finished the day 0.56% higher at 1,878.21. During the trading session, eight out of ten sectors finished on a positive note. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include TripAdvisor Inc. (NASDAQ: TRIP), Canadian Solar Inc. (NASDAQ: CSIQ), American Capital Ltd (NASDAQ: ACAS) and Aegerion Pharmaceuticals Inc (NASDAQ: AEGR). Free technical research on TRIP, CSIQ, ACAS and AEGR can be downloaded upon signing up at:

http://www.investor-edge.com/2277-register

On Wednesday, shares in TripAdvisor Inc. finished the session 3.22% higher at $83.99. A total of 7.14 million shares were traded, much above its three months average volume of 2.54 million shares. The stock moved between $80.16 and $86.16 during the session. TripAdvisor Inc.'s shares have gained 1.68% over the previous three trading sessions and 0.76% in the last one month. Also, the stock has advanced 1.40% on YTD basis. The S&P 500 Consumer Discretionary Sector Index fell by 1.24% in the previous three months, while the NASDAQ Composite Index declined 1.41% during the same period. The company's shares are trading below their 50-day moving average. Moreover, the stock's 50-day moving average of $92.77 is greater than its 200-day moving average of $82.89. TripAdvisor Inc.'s stock traded at a PE ratio of 57.92 and has a Relative Strength Index of 43.01. Sign up today to read free research on TRIP at:

http://www.investor-edge.com/2277-TRIP-08May2014.pdf

Shares in Canadian Solar Inc. recorded a trading volume of 6.32 million shares, above its three months average volume of 4.39 million shares. The stock ended the day at $27.25, which was 0.96% higher its previous day's closing, and registered an intraday range of $26.12 and $28.85. However, Canadian Solar Inc.'s stock has declined 1.05% in the previous three trading sessions, 3.88% in the last one month and 8.62% since the start of this year. Shares of the company traded at a PE ratio of 52.40. The S&P 500 Information Technology Sector Index advanced 1.33% in the previous one month, while the NASDAQ Composite Index fell by 0.30% during the same period. Canadian Solar Inc.'s stock is trading below its 50-day moving average. The stock's 50-day moving average of $32.29 is above its 200-day moving average of $26.88. Furthermore, shares of the company have an RSI of 41.99. Sign up today to read free research on CSIQ at:

http://www.investor-edge.com/2277-CSIQ-08May2014.pdf

American Capital Ltd's stock fluctuated between $15.25 and $16.03 before ending the day 6.26% higher at $15.95. The company's stock reported a trading volume of 11.47 million shares on Wednesday, much above its three months average volume of 3.11 million shares. Shares in American Capital Ltd have gained 6.05% in the previous three trading sessions and 5.84% in the last one month. Additionally, the stock has advanced 1.98% on YTD basis. The S&P 500 Financials Sector Index edged lower by 0.01% on YTD basis, while the NASDAQ Composite Index fell by 2.61% during the same period. The company's stock is trading above its 50-day and 200-day moving averages of $14.98 and $14.49, respectively. Moreover, the company's shares have an RSI of 54.01. Sign up today to read free research on ACAS at:

http://www.investor-edge.com/2277-ACAS-08May2014.pdf

Shares in Aegerion Pharmaceuticals Inc. fell by 21.58% on Wednesday, closing the day at $34.63. The stock recorded a trading volume of 8.19 million shares, much above its three months average volume of 1.07 million shares. The stock oscillated between $30.43 and $36.55 during the trading session. Aegerion Pharmaceuticals Inc.'s stock has lost 20.39% in the previous three trading sessions and 19.30% in the last one month. Also, the company's stock has declined 51.20% since the start of this year. On May 06, 2014, Aegerion Pharmaceuticals Inc. announced its Q1 FY 2014 (period ended March 31, 2014) financial results. The company reported that its Q1 FY 2014 GAAP net loss stood at $15.8 million, or $0.54 per share, compared with a GAAP net loss of $18.1 million, or $0.64 per share, for the same quarter in 2013. Sign up today to read free research on AEGR at:

http://www.investor-edge.com/2277-AEGR-08May2014.pdf

EDITOR'S NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge